FDA Inspection 1026375 — Maria Wisniewska-Jarosinska, MD, PhD
The FDA completed an inspection of Maria Wisniewska-Jarosinska, MD, PhD on Sep 20, 2017 in Lodz. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 20, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lodz (Poland)
Additional details
Clinical Investigator (CI)
Citations
| ID | CFR | Description |
|---|---|---|
| 7531 | 21 CFR 312.62(c) | Record retention |